Policy paper
Vaccine research relief: expiry in 2017
This tax information and impact note applies to companies that carry out R&D into prescribed types of vaccine and other medicine.
Documents
Details
This measure provides for the expiry of vaccine research relief, in respect of expenditure incurred on or after 1 April 2017.
Updates to this page
Published 16 March 2016